“Thiopurine-Allopurinol Combination Therapy May Improve Tolerability and Efficacy in Inflammatory Bowel Disease: A Clinical Trial”

https://pubmed.ncbi.nlm.nih.gov/38095246

The abstract describes a clinical trial showing that thiopurine-allopurinol combination therapy in inflammatory bowel disease patients may enhance tolerability and efficacy of thiopurines by reducing adverse effects.